ARUP's Laboratory Test Directory

Virilization Panel 1 : 2002028

Mnemonic: VIRIL PANEL

Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed: Sun-Sat
Reported: 1-4 days
Specimen Required: Collect: Serum separator tube or green (sodium or lithium heparin). Collect between 6-10 a.m. Also acceptable: Lavender (EDTA).

Specimen Preparation: Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min 0.5 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 2 hours; Refrigerated: 1 week; Frozen: 6 months

Reference Interval:
Test Number Components Reference Interval
2001638Androstenedione Effective November 14, 2011
Age Female Male
Premature Infants, 26-28 weeks-Day 4
Premature Infants, 31-35 weeks-Day 4
Full-term Infants, 1-7 days
8-30 days
1-5 months
6-24 months
2-3 years
4-5 years
6-7 year
8-9 years
10-11 years
12-13 years
14-15 years
16-17 years
18-39 years
40 years and older
Pre-menopausal
Postmenopausal
0.92-2.82 ng/mL
0.80-4.46 ng/mL
0.20-2.90 ng/mL
0.18-0.80 ng/mL
0.06-0.68 ng/mL
Less than 0.15 ng/mL
Less than 0.16 ng/mL
0.02-0.21 ng/mL
0.02-0.28 ng/mL
0.04-0.42 ng/mL
0.09-1.23 ng/mL
0.24-1.73 ng/mL
0.39-2.00 ng/mL
0.35-2.12 ng/mL
0.26-2.14 ng/mL
0.13-0.82 ng/mL
0.26-2.14 ng/mL
0.13-0.82 ng/mL
0.92-2.82 ng/mL
0.80-4.46 ng/mL
0.20-2.90 ng/mL
0.18-0.80 ng/mL
0.06-0.68 ng/mL
0.03-0.15 ng/mL
Less than 0.11 ng/mL
0.02-0.17 ng/mL
0.01-0.29 ng/mL
0.03-0.30 ng/mL
0.07-0.39 ng/mL
0.10-0.64 ng/mL
0.18-0.94 ng/mL
0.30-1.13 ng/mL
0.33-1.34 ng/mL
0.23-0.89 ng/mL
Tanner Stage I
Tanner Stage II
Tanner Stage III
Tanner Stage IV-V
0.05-0.51 ng/mL
0.15-1.37 ng/mL
0.37-2.24 ng/mL
0.35-2.05 ng/mL
0.04-0.32 ng/mL
0.08-0.48 ng/mL
0.14-0.87 ng/mL
0.27-1.07 ng/mL
2001640Dehydroepiandrosterone, Serum or Plasma Effective November 14, 2011
Age Female Male
Premature:
0-1 day
2-6 days
7 days-1 month
1-5 months
6-24 months
2-3 years
4-5 years
6-7 years
8-9 years
10-11 years
12-13 years
14-15 years
16-17 years
18-39 years
40 years and older
Postmenopausal
Less than 40 ng/mL
Less than 11 ng/mL
Less than 8.7 ng/mL
Less than 5.8 ng/mL
Less than 2.9 ng/mL
Less than 1.9 9 ng/mL
Less than 0.85 ng/m
Less than 1.03 ng/mL
Less than 1.79 ng/mL
0.14-2.35 ng/mL
0.43-3.78 ng/mL
0.89-6.21 ng/mL
1.22-7.01 ng/mL
1.42-9.00 ng/mL
1.33-7.78 ng/mL
0.63-4.70 ng/mL
0.60-5.73 ng/mL
Less than 40 ng/mL
Less than 11 ng/mL
Less than 8.7 ng/mL
Less than 5.8 ng/mL
Less than 2.9 ng/mL
Less than 2.5 ng/mL
Less than 0.63 ng/mL
Less than 0.95 ng/mL
0.06-1.93 ng/mL
0.10-2.08 ng/mL
0.32-3.08 ng/mL
0.57-4.10 ng/mL
0.93-6.04 ng/mL
1.17-6.52 ng/mL
1.33-7.78 ng/mL
0.63-4.70 ng/mL
Tanner Stage I
Tanner Stage II
Tanner Stage III
Tanner Stage IV-V
0.14-2.76 ng/mL
0.83-4.87 ng/mL
1.08-7.56 ng/mL
1.24-7.88 ng/mL
0.11-2.37 ng/mL
0.37-3.66 ng/mL
0.75-5.24 ng/mL
1.22-6.73 ng/mL
0081058Testosterone, Females or Children Effective November 14, 2011
Serum Total Testosterone, Determined by LC-MS/MS
Female Male
Premature (26-28 weeks): 5-16 ng/dL
Premature (31-35 weeks): 5-22 ng/dL
Newborn: 20-64 ng/dL
1-5 months: Less than 20 ng/dL
6-24 months: Less than 9 ng/dL
2-3 years: Less than 20 ng/dL
4-5 years: Less than 30 ng/dL
6-7 years: Less than 7 ng/dL
8-9 years: 1-11ng/dL
10-11 years: 3-32 ng/dL
12-13 years: 6-50 ng/dL
14-15 years: 6-52 ng/dL
16-17 years: 9-58 ng/dL
18-39 years: 9-55 ng/dL
40-59 years: 9-55 ng/dL
60 years and older: 5-32 ng/dL
Premenopausal (Greater than 18 years): 9-55 ng/dL
Postmenopausal: 5-32 ng/dL
Tanner Stage I: 2-17 ng/dL
Tanner Stage II: 5-40 ng/dL
Tanner Stage III: 10-63 ng/dL
Tanner Stage IV-V: 11-62 ng/dL
Premature (26-28 weeks): 59-125 ng/dL
Premature (31-35 weeks): 37-198 ng/dL
Newborn: 75-400 ng/dL
1-5 months: 14-363 ng/dL
6-24 months: Less than 37 ng/dL
2-3 years: Less than 15 ng/dL
4-5 years: Less than 19 ng/dL
6-7 years: Less than 13 ng/dL
8-9 years: 2-8 ng/dL
10-11 years: 2-165 ng/dL
12-13 years: 3-619 ng/dL
14-15 years: 31-733 ng/dL
16-17 years: 158-826 ng/dL
18-39 years: 300-1080 ng/dL
40-59 years: 300-890 ng/dL
60 years and older: 300-720 ng/dL
Tanner Stage I: 2-15 ng/dL
Tanner Stage II: 3-303 ng/dL
Tanner Stage III: 10-851 ng/dL
Tanner Stage IV-V: 162-847 ng/dL

Interpretive Data: Total testosterone values may not reflect optimal concentrations in all individuals. Free or bioavailable testosterone measurements may provide supportive information.

See Compliance Statement B: www.aruplab.com/CS
CPT Code(s): 82157; 82626; 84403
Cross References: Androstenedione (Virilization Panel 1), Dehydroepiandrosterone (Virilization Panel 1), Testosterone (Virilization Panel 1)